SELECTIVE TARGETING OF ADJUVANT THERAPY FOR ENDOMETRIAL CANCER: THE STATEC TRIAL

Grant number: 1080706 | Funding period: 2015 - 2019

Completed

Abstract

This international collaborative trial for women with aggressive endometrial cancer will investigate whether lymph node removal (lymphadenectomy) at time of hysterectomy is needed to predict whether patients need additional treatment, compared to not removing the lymph nodes and giving additional treatment to all such patients. If we can select patients who need further treatment more accurately, we will avoid giving patients unnecessary toxic treatment which impacts on their quality of life.